Wolfe Research starts Gilead at Outperform on ‘multiple shots on goal’
Wolfe Research initiated coverage of Gilead (GILD) with an Outperform rating and $110 price target Gilead’s bread and butter has been ...
Gilead, Vertex initiated as new big biotech buys at Citi
Citi initiates coverage of Gilead Sciences and Vertex Pharmaceuticals at buy in the large U.S. biotech sector. Read more here.
Citi initiates coverage on 5 new biotech stocks
Citigroupa expanded its biotech coverage on Wednesday, adding five more stocks to the roster including Amgen (NASDAQ:AMGN), Biogen (NASDAQ:BIIB), Gilead (NASDAQ:GILD), Regeneron (NASDAQ:REGN), and ...
modernghana.com15h
Inconvenient question: Science is gifting us new HIV prevention tools but is it expanding choices for the people?
Any new HIV prevention method is not meant to sit on the shelf but to be used by the people who need it to protect themselves ...